Atlante Private Equity, a private equity fund managed by IMI Fondi Chiusi SGR, has acquired an interest in Svas Biosana, a company based in Somma Vesuviana (Naples) that has been operating for over 40 years in the medical devices and infusion solutions sector.
Atlante has invested EUR6 million to acquire a minority interest in the company.
“We are delighted to welcome the Atlante Private Equity Fund as one of our shareholders,” says Umberto Perillo, managing director of the Svas Biosana Group. “In such an unsettled economic environment, tackling the challenges posed by the market with the daily support of a financial investor stimulates our growth and consolidation in a sector where competition is becoming ever fiercer”.
“The decision to support the growth of the Svas Biosana Group is based on the Management Team’s skills and great motivations. These factors represent the best conditions for implementing the growth path that the Group has drawn up,” says Antonio Finocchi Ghersi, one of Atlante Private Equity Fund’s senior partners. “The Svas Biosana Group has, over time, demonstrated the ability to readily adopt strategies designed to tangibly meet market needs. Further potential elements to be exploited make us confident that targets set will be achieved” added Antonio Riccio, the Fund’s Investment Director.
Atlante Private Equity was advised by PWC Transaction Services, with Roberto Leccese of Law Firm Studio Ughi e Nunziante acting as legal advisor. Svas Biosana was advised at the contract stage by Attilio Ferrari and Andrea Pedeferri of Law Firm CFMP Studio Legale Associato.
